29.95 USD
▼+0.13-7.07%
盘后 32.48 +0.78%
2026-08-03
市值
$2.15B
市盈率
—
EPS
-5.58
股息率
—
52 周区间
19.07 – 56.05
成交量
5.14M
Beta
0.92
目标价
81.79
52W 低 19.0752W 高 56.05
价格走势
公司简介
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a ...